Novavax says it could start making Omicron-specific vaccine in January

Go back to Novavax says it could start making Omicron-specific vaccine in January
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.45 -0.34 (3.87%)
Previous Close $8.79    52 Week High $9.23 
Open $8.50    52 Week Low $1.16 
Day High $8.66    P/E N/A 
Day Low $8.02    EPS $-0.30 
Volume 4,412,836